News
JCTR welcomes 2 new Editors-in-Chief
December 1, 2023
Jacek Z. Kubiak - translational research
Prof. Kubiak studied Biology at Warsaw University, Poland, and graduated with an MS in 1983. He then joined the research group of Prof. Andrzej K. Tarkowski at the Institute of Zoology, Department of Biology, Warsaw University. He received his PhD degree in 1988 at the same institution. After three years of postdoctoral fellowship supervised by Dr Bernard Maro at the Institute Jacques Monod, Paris, France, he obtained a position at the CNRS in France. He is now in the CNRS, France, and WIM-PIB in Poland. He has published more than 140 research articles in SCI(E) journals.
Ken H Young - clinical research
Prof. Young is a clinically oriented diagnostic physician with clinical expertise in the pathologic diagnosis of hematologic cancers, including tumors of the bone marrow, lymphoid tissue, spleen, and pre-malignant hematologic conditions. Another area of interest is blood cancer classification with molecular and genetic profiling. In his research program, the team focuses on molecular mechanisms of tumor progression, cell-of-origin, biomarkers, and novel therapeutic strategies in lymphoma, myeloma, and leukemia. In addition to patient care and translational research, medical education and scientific communication are also part of interest. He provides persistent support for the physician-scientist program and Blood Cancer Pathology program in the department and cancer center. Many residents, fellows, graduates, and postdocs have worked and been trained in his program. They perform comprehensive clinical and research functions that include bone marrow, lymphoma pathology, clinical flow cytometry, cytogenetics, molecular diagnostics, and outside services.
JCTR welcomes four new editorial board members
May 18, 2023
Simon Rabkin - clinical editorial board
Dr Simon Rabkin is a Professor of Medicine in the Division of Cardiology at the University of British Columbia (UBC), Canada. He graduated with an MD from the University of Manitoba. He did postgraduate Internal Medicine and Cardiology training at the University of Toronto, the University of Cincinnati, and Emory University. His research interests are in the determinants of cardiovascular disease and its therapy. He is especially interested in the consequences of hypertension on the development of dementia, aortic aneurysms, and cardiac disease. His research interests and activities have spanned the range of basic science, clinical investigation, clinical trials, and epidemiology. He has published over 230 scientific papers or book chapters. He has served on many Canadian consensus conferences to develop best practice guidelines for Canadian Physicians. He is the current chair of the subcommittee on the pharmacologic management of patients with hypertension and cardiac disease for the Canadian Hypertension Education Program (CHEP).
Marcello Covino - clinical editorial board
Marcello Covino, MD, PhD., is an assistant professor at Emergency Medicine, Università Cattolica del Sacro Cuore, Rome, Italy, with broad research interests in Medical and surgical emergencies in older adults, acute diverticulitis, acute pancreatitis, sepsis, infection in an emergency, procalcitonin, trauma, head trauma, early warning scores, COVID-19. With his expertise in clinical activity, he has published 111 papers in peer-reviewed journals from 1993 to the present, and more than 300 abstracts presented in national and international meetings. He is a Member of the Italian Society of Emergency Medicine (SIMEU) and the Italian Society of Internal Medicine (SIMI).
Yan Gong - translational editorial board
Dr. Yan Gong is engaged in basic research on angiogenesis, lipid metabolism, and tumor immunity at Zhongnan Hospital of Wuhan University. He graduated from the University of Maine and got postdoctoral training at Boston Children’s Hospital, Harvard Medical School. He participated in the establishment of the Human Genetics Resource Preservation Center of Hubei Province and Tumor Precision Diagnosis and Treatment Technology and Translational Medicine, Hubei Engineering Research Center. Dr. Gong published more than 100 scientific papers in journals including but not limited to Angiogenesis, Metabolism, and Cancer Letters. He has been supported by the National Natural Science Foundation of China, the National Key Research and Development Program of China, and the Key Research and Development Program of Hubei Province.
Yufeng Zhou - translational editorial board
Yufeng Zhou got his B.S. (1996) and M.S. (1999) degrees from the National Key Lab of Modern Acoustics, Institute of Acoustics, Nanjing University, China. He obtained his Ph.D. degree from the Department of Mechanical Engineering and Materials Science at Duke University and majored in Bioacoustics in 2003.
Dr. Zhou worked at Duke University between 2003 and 2006, at ImaRx Therapeutics Inc. in 2006, at the University of Washington from 2006 to 2010, and at Nanyang Technological University from 2010 to 2020. Since 2021, he joined Chongqing Medical University as a professor at the College of Biomedical Engineering, State Key Laboratory of Ultrasound in Medicine and Biology, National Engineering Research Center of Ultrasound Medicine. His recent research interests are biomedical ultrasound in therapy and diagnosis, nondestructive evaluation and testing, and acoustics.
Journal ownership change notice
May 10, 2023
Since May 10, 2023, the ownership of the Journal of Clinical and Translational Research has been transferred from Whioce Publishing to AccScience Publishing. The journal is now under the ownership and management of the new publisher. The Editorial Board remains unchanged.
Publisher office
AccScience Publishing
8 Burn Road#15-03 Trivex Singapore 369977
